Article Text

Download PDFPDF
Finasteride drug safety alert

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a safety alert after receiving reports of depression and, in rare cases, suicidal thoughts in men taking finasteride 1mg.1 The MHRA has also reminded healthcare professionals that depression is also associated with finasteride 5mg.

Finasteride is a 5α-reductase-type-2 inhibitor. The 1mg dose is licensed for the …

View Full Text